24/7 Market News – (NASDAQ:IKNA) shares are moving higher this morning on FDA fast track news.

June 22, 2022

$3.53 shares are up 1% pre market with over 5303 trades.

Ikena Oncology Receives FDA Fast Track Designation for Novel TEAD Inhibitor IK-930 to Treat Unresectable NF2-Deficient Mesothelioma

https://www.nasdaq.com/press-release/ikena-oncology-receives-fda-fast-track-designation-for-novel-tead-inhibitor-ik-930-to

Pages: 1 2 3

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.